Biogen Inc. (BIIB) exhibits a short-term neutral trend within a longer-term uptrend structure. The stock has consolidated around the 183 level after a 1-month decline of about 4%, but recent sessions show resilience with a 1.5% daily gain. TradingView's community leans bullish with 9 bullish ideas versus 1 bearish. The price holds above major longer-term moving averages, suggesting underlying support, while hovering below shorter-term averages indicates caution in the immediate term.
Critical support levels cluster between 180.36 and 182.96, reinforced by trend lines and moving averages, with further downside zones at 176.30-176.76 and 172.33-172.96. Classic pivot points highlight S1 at 182.18, S2 at 181.66, and S3 at 180.85. On the upside, immediate resistance sits at R1 183.52, R2 184.34, and R3 184.86, with stronger barriers at 189.20-190.48 and 196.80. A sustained break above 184 could target higher resistance near 190, while a drop below 182 may test the 180 zone.
The Relative Strength Index (RSI) at 47.97-51.02 remains in neutral territory, signaling balanced momentum without extreme conditions that could prompt sharp reversals. MACD readings are divergent across sources—one at -0.65 indicating a sell, the other at 0.73 showing positive momentum albeit declining—pointing to indecision in directional strength. Overall, oscillators lean sell (5 sells, 2 buys, 3 neutrals), tempering bullish enthusiasm.
Moving averages present a buy summary (9 buys, 3 sells), with the price above the MA100 SMA (181.06), MA200 SMA (181.76), and most EMAs except MA20 (183.69) and MA50 (183.52). The 5-day SMA at 183.12 and 10-day at 182.32 act as near-term support. This configuration supports a constructive longer-term posture but highlights resistance from shorter-term averages around 183-185.
Recent volume stands at 849,234 shares versus an average of 1.24 million, indicating moderate participation amid consolidation. Price action over the last 30 days shows sideways trading within a tightening range near 183, with the stock rebounding from intraday lows around 181.89. The 52-week range of 115.25-202.41 underscores the significance of holding above 180 to maintain the recovery narrative.
Tickeron’s AI Daily Buy/Sell Signals leverage artificial intelligence to scrutinize vast arrays of market data, technical indicators, and historical price patterns for Biogen Inc. (BIIB). These signals identify potential buy or sell opportunities based on trend recognition, momentum shifts, and recurring chart behaviors observed in similar conditions. Traders rely on them to pinpoint entry and exit points, validate ongoing trends, and bolster decision-making processes with data-driven insights. Explore the AI signals to enhance your technical trading strategy.
Traders will monitor a decisive move above 184-185 to challenge resistance at 189-190, potentially confirming bullish continuation toward 196. Conversely, failure at current pivots could see tests of support at 182 and 180. Key indicators like RSI for divergence and MACD crossovers remain focal points, alongside volume confirmation on any breakout. The balance between short-term resistance and long-term support will dictate the next directional phase in this consolidation.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
A.I.dvisor indicates that over the last year, BIIB has been loosely correlated with AMGN. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if BIIB jumps, then AMGN could also see price increases.
| Ticker / NAME | Correlation To BIIB | 1D Price Change % | ||
|---|---|---|---|---|
| BIIB | 100% | +1.56% | ||
| AMGN - BIIB | 52% Loosely correlated | -1.78% | ||
| PFE - BIIB | 51% Loosely correlated | -0.46% | ||
| AZN - BIIB | 49% Loosely correlated | -0.46% | ||
| MRK - BIIB | 46% Loosely correlated | +0.23% | ||
| BMY - BIIB | 41% Loosely correlated | -1.14% | ||
More | ||||